Company Search:
Advanced Search
Sponsored Links
Human Metabolome Technologies Inc Company Snapshot
Human Metabolome Technologies Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Human Metabolome Technologies Inc with three other companies in this sector in Japan: Nanocarrier Company Limited (2019 sales of 496.73 million Japanese Yen [US$4.57 million] ), Gene Techno Science Co Ltd (1.02 billion Japanese Yen [US$9.41 million] of which 100% was pharmaceutical development), and SanBio Co Ltd (741.61 million Japanese Yen [US$6.83 million] of which 100% was Allogeneic cell transplantation).

Sales Analysis. Human Metabolome Technologies Inc reported sales of ¥791.51 million (US$7.29 million) for the fiscal year ending March of 2019. This represents a decrease of 15.6% versus 2018, when the company's sales were ¥938.18 million. Contributing to the drop in overall sales was the 84.9% decline in Biomarker Business, from ¥2.15 million to ¥324,000.00 . There were also decreases in sales in Metabolome Analysis Business (down 15.5% to ¥791.19 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Human Metabolome Technologies Inc
  Stock Performance Chart for Human Metabolome Technologies Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 839.00
(Figures in Japanese Yen)
1 Week 2.4%   13 Weeks 1.5%  
4 Weeks 0.5%   52 Weeks -43.0%  
Human Metabolome Technologies Inc Key Data:
  Ticker: 6090 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 791,512,800
(Year Ending Jan 2020).
Employees: 61
  Currency: Japanese Yen Market Cap: 4,911,276,953
  Fiscal Yr Ends: March Shares Outstanding: 5,853,727
  Share Type: Ordinary Closely Held Shares: 1,475,100
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.